AIMOVIG is not covered on the Reformulary. Reformulary covers two preferred drugs in the CGRP antagonist class of drugs: AJOVY (fremanezumab) and VYEPTI (eptinezumab). Both drugs require Special Authorization.
 

AIMOVIG is used to treat  
Migraines